ARTV vs EIX · rev $251.0K vs P/E 7.3, rev $17.60B
Artiva Biotherapeutics, Inc. Common Stock (ARTV) versus Edison International (EIX) — a side-by-side from cached financials, not a winner call.
Artiva Biotherapeutics, Inc. Common Stock (ARTV) is a biotechnology company listed on US.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Latest reported ARTV revenue for 2024-12-31 was $251.0K. Net income was -$65.4M. Revenue was down 99.3% from 2023-12-31 to 2024-12-31. ARTV currently screens at market cap $37.3M.
Latest reported EIX revenue for 2024-12-31 was $17.60B. Net income was $1.55B. Revenue was up 7.7% from 2023-12-31 to 2024-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
ARTV currently screens at market cap $37.3M. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Not investment advice. Open the ARTV and EIX stock pages for the full models.
Not investment advice.